[ad_1]
FILE PHOTO: Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – Moderna Inc said on Thursday it expects mid-stage trials for its COVID-19 vaccine to begin shortly while late-stage trials are expected to begin early summer, sending shares of the drug developer up 12% before the bell.
Previously, the company had said it planned to begin mid-stage trials in early summer.
Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Supriya Kurane; Editing by Supriya Kurane
[ad_2]
Source link